west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "王文平" 2 results
  • Role of Contrast-Enhanced Ultrasonography in The Detection and Diagnosis of Small Primary Liver Cancer

    Objective To investigate the value of contrast-enhanced ultrasonography in detection and diagnosis of small primary liver cancer. Methods SonoVue-enhanced ultrasonography were performed on 353 patients with 378 primary liver cancer, less than 3 cm in diameter. Enhancement patterns and enhancement phases of hepatic lesions on contrast-enhanced ultrasonography were analyzed and compared with the results of histopathology. Results In all hepatic tumors, 96.6% (365/378) lesions enhanced in the arterial phase. Among them, 317 (83.9%) tumors enhanced earlier than liver parenchyma and 48 (12.7%) tumors enhanced synchronously with liver parenchyma, and 342 (90.5%) tumors showed early wash-out in the portal and late phases. With regard to the enhancement pattern, 329 (87.0%) tumors presented whole-lesion enhancement, 35 (9.3%) to be mosaic enhancement and 14 (3.7%) to be rim-like enhancement. If taking the whole-lesion enhancement and mosaic enhancement in arterial phase as diagnotic standard for primary liver cancer on contrast-enhanced ultrasonography, the sensitivity was 92.9%(351/378), and if the earlier or synchronous enhancement of the tumor compared with liver parenchyma in arterial phase and the wash-out in portal phase were regarded as the stardand, the sensitivity was 87.3%(330/378). Conclusion Contrast-enhanced ultrasonography could display real-time enhancement patterns as well as the wash-out processes both in hepatic tumors and the liver parenchyma. It might be of clinical value in diagnosis of primary liver cancer based on the hemodynamics of hepatic tumors on contrast-enhanced ultrasonography.

    Release date:2016-08-28 04:08 Export PDF Favorites Scan
  • 阿德福韦酯对乙型肝炎病毒e抗原阴性慢性乙型肝炎患者T细胞亚群的影响

    目的探讨阿德福韦酯对乙型肝炎病毒e抗原(HBeAg)阴性慢性乙型肝炎患者外周血T细胞亚群的影响。 方法对2012年5月-2013年5月56例慢性乙型肝炎患者常规给予护肝治疗,同时给予口服阿德福韦酯10 mg,1次/d,疗程48周。检测服药前及48周后肝功能、乙型肝炎病毒(HBV) DNA及T细胞亚群。 结果经口服阿德福韦酯治疗48周后,患者血清HBV-DNA滴度较治疗前明显下降,肝功能明显改善,CD4+T淋巴细胞百分比(37.3%) 较治疗前(32.8%) 明显升高(P<0.001),CD4+/CD8+(1.37) 较治疗前(1.11) 升高(P<0.005)。 结论阿德福韦酯治疗HBeAg阴性慢性乙型肝炎,在抑制HBV的复制、减轻肝脏炎症反应的同时,也可能改善了慢性乙型肝炎患者的细胞免疫功能。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content